Core Viewpoint - The animal health sector experienced a rise of 0.98% on September 30, with *ST Lvkang leading the gains, while the overall market indices also showed positive movement [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 3882.78, up 0.52% [1]. - The Shenzhen Component Index closed at 13526.51, up 0.35% [1]. - The animal health sector's individual stock performance is detailed in a table, highlighting various stocks' closing prices and percentage changes [1]. Group 2: Stock Performance - *ST Lvkang (002868) closed at 28.01, with a gain of 3.51% and a trading volume of 16,700 shares, amounting to approximately 46.61 million yuan [1]. - Other notable stocks include: - Biological Shares (600201) at 9.64, up 1.69% with a trading volume of 412,400 shares [1]. - Jinhe Biological (002688) at 6.69, up 1.67% with a trading volume of 150,600 shares [1]. - KQ Bio (688526) at 17.72, up 1.37% with a trading volume of 32,700 shares [1]. Group 3: Capital Flow - The animal health sector saw a net inflow of 3.40 million yuan from institutional investors, while retail investors experienced a net outflow of 28.01 million yuan [2][3]. - The detailed capital flow for individual stocks indicates varying levels of net inflow and outflow among different companies [3]. - For instance, Biological Shares (600201) had a net inflow of approximately 19.60 million yuan from institutional investors, while *ST Lvkang (002868) faced a net outflow of about 6.49 million yuan [3].

Core Insights - The animal health sector experienced a slight increase of 0.46% on September 29, with Shenlian Biological leading the gains [1] - The Shanghai Composite Index closed at 3862.53, up 0.9%, while the Shenzhen Component Index closed at 13479.43, up 2.05% [1] Stock Performance - Shenlian Biological (688098) closed at 10.59, up 1.92% with a trading volume of 68,700 shares and a turnover of 72.32 million yuan [1] - Other notable performers included: - Biological Shares (600201) at 9.48, up 1.50% with a turnover of 503 million yuan [1] - Pulaike (603566) at 13.78, up 1.03% with a turnover of 54.30 million yuan [1] - Zhongmu Shares (600195) at 7.12, up 0.85% with a turnover of 49.02 million yuan [1] Capital Flow - The animal health sector saw a net outflow of 7.69 million yuan from institutional investors, while retail investors contributed a net inflow of 8.08 million yuan [2] - The detailed capital flow for key stocks includes: - Shenlian Biological: net outflow of 5.50 million yuan from retail investors [3] - Biological Shares: net outflow of 7.67 million yuan from retail investors [3] - Pulaike: net outflow of 4.08 million yuan from retail investors [3]

Market Overview - On September 25, the animal health sector declined by 1.62% compared to the previous trading day, with the leading stock, Driveline, experiencing a drop of 4.04% [1] - The Shanghai Composite Index closed at 3853.3, down 0.01%, while the Shenzhen Component Index closed at 13445.9, up 0.67% [1] Stock Performance - The following stocks in the animal health sector showed notable declines: - Driveline (Code: 838275) closed at 9.50, down 4.04% with a trading volume of 19,300 lots [1] - Shunlian Bio (Code: 688098) closed at 10.43, down 3.43% with a trading volume of 76,300 lots [1] - Yongshun Bio (Code: 839729) closed at 9.74, down 2.89% with a trading volume of 20,800 lots [1] - Other notable declines include *ST Green Health (Code: 002868) down 2.39% and Shoufeng Holdings (Code: 002141) down 2.33% [1] Capital Flow - The animal health sector saw a net outflow of 113 million yuan from institutional investors, while retail investors experienced a net inflow of 61.16 million yuan [1] - The following stocks had significant capital flow: - Zhongmu Co. (Code: 600195) had a net inflow of 986,800 yuan from institutional investors [2] - Pulaike (Code: 603566) saw a net inflow of 764,200 yuan from retail investors [2] - *ST Green Health (Code: 002868) experienced a net outflow of 6.71 million yuan from institutional investors [2]

证券代码：839729 证券简称：永顺生物 公告编号：2025-094 一、 投资者关系活动类别 □特定对象调研 □业绩说明会 □媒体采访 广东永顺生物制药股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 活动时间：2025 年 9 月 19 日 15:30-17:00 活动地点：本次活动采用网络远程的方式举行，投资者通过登录"全景路演" 网站（https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP, 参与本次互动交流。 参会单位及人员：通过网络方式参与 2025 年广东辖区上市公司投资者网上 集体接待日活动的投资者 上市公司接待人员：公司董事、总经理吴锋先生，副总经理、财务负责人李 秋红女士，副总经理、董事会秘书林建新先生 三、 投资者关系活动主要内容 □现场参观 □新闻发布会 □分析师会议 □路演活动 √其他 (2025 年广东辖区上市公司投资者网上集体接待日活动) 二、 投资者关系活动情况 问题 4：公司提出"渠道下沉、服务终端 ...

Market Overview - On September 19, the animal health sector declined by 0.26% compared to the previous trading day, with the driving force leading the decline [1] - The Shanghai Composite Index closed at 3820.09, down 0.3%, while the Shenzhen Component Index closed at 13070.86, down 0.04% [1] Stock Performance - Notable stock movements included: - *ST Lvkang (002868): Closed at 27.56, up 4.99% with a trading volume of 38,500 shares and a turnover of 105 million yuan [1] - Kexin Biological (688526): Closed at 18.08, up 0.39% with a trading volume of 22,700 shares and a turnover of 40.94 million yuan [1] - Driving Force (838275): Closed at 10.50, down 4.11% with a trading volume of 21,200 shares and a turnover of 22.63 million yuan [2] Capital Flow - The animal health sector experienced a net outflow of 91.4 million yuan from institutional investors, while retail investors saw a net inflow of 70.15 million yuan [2] - The capital flow for individual stocks showed: - RuiPu Biological (300119): Net inflow of 16.56 million yuan from institutional investors, but a net outflow of 21.57 million yuan from retail investors [3] - *ST Lvkang (002868): Net inflow of 6.13 million yuan from institutional investors, with a net outflow of 4.21 million yuan from retail investors [3]

Market Overview - On September 18, the animal health sector declined by 0.77% compared to the previous trading day, with Huisheng Biological leading the decline [1] - The Shanghai Composite Index closed at 3831.66, down 1.15%, while the Shenzhen Component Index closed at 13075.66, down 1.06% [1] Stock Performance - The following stocks in the animal health sector showed notable performance: - *ST Lvkang (002868): Closed at 26.25, up 5.00% with a trading volume of 3433 lots [1] - Shengbi Biological (600201): Closed at 66.8, down 2.39% with a trading volume of 55.74 million [1] - Ruipu Biological (300119): Closed at 22.06, unchanged with a trading volume of 111.3 million [1] - Other stocks such as Jinhai Biological (002688) and Shunlian Biological (688098) also experienced declines of 1.98% and 2.02% respectively [1][2] Capital Flow - The animal health sector experienced a net outflow of 126 million yuan from institutional investors, while retail investors saw a net inflow of 92.38 million yuan [2] - The following stocks had significant capital flow: - Ruipu Biological: Net inflow of 12.35 million yuan from institutional investors [3] - *ST Lvkang: Net outflow of 3.83 million yuan from institutional investors [3] - Jinhai Biological: Net outflow of 25.51 million yuan from institutional investors [3]

Market Overview - On September 16, the animal health sector declined by 0.41%, with *ST Lvkang leading the drop [1] - The Shanghai Composite Index closed at 3861.87, up 0.04%, while the Shenzhen Component Index closed at 13063.97, up 0.45% [1] Stock Performance - Key stocks in the animal health sector showed mixed performance, with the following notable movements: - Xianfeng Holdings (002141) increased by 2.27% to close at 4.06 [1] - Haili Biological (603718) rose by 1.27% to 7.17 [1] - *ST Lvkang (002868) fell by 4.34% to 23.81, leading the decline [2] - The trading volume and turnover for selected stocks were significant, with Xianfeng Holdings achieving a turnover of 1.02 billion [1] Capital Flow Analysis - The animal health sector experienced a net outflow of 15.97 million from institutional investors, while retail investors saw a net inflow of 11.29 million [2][3] - Notable capital flows included: - Biological Shares (600201) had a net inflow of 12.28 million from institutional investors [3] - *ST Lvkang (002868) saw a net outflow of 2.89 million from institutional investors [3] - Retail investors contributed positively to several stocks, including a net inflow of 12.59 million into Shenyuan Biological (688098) [3]

证券代码：839729 证券简称：永顺生物 公告编号：2025-091 广东永顺生物制药股份有限公司职工代表董事任命公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 （一）《广东永顺生物制药股份有限公司 2025 年第一次职工代表大会决议》 广东永顺生物制药股份有限公司（以下简称"公司"）于 2025 年 9 月 15 日召开 2025 年第一次职工代表大会，审议通过了《关于选举公司第五届董事会职工代表董事的议 案》。 选举林宝君女士为公司职工代表董事，任职期限至第五届董事会任期届满之日止， 自 2025 年 9 月 15 日起生效。该人员持有公司股份 50,000 股，占公司股本的 0.0183%， 不是失信联合惩戒对象。 （上述人员简历详见附件） 二、合规性说明及影响 （一）人员变动的合规性说明 公司新任职工代表董事林宝君女士的任职资格符合法律法规、部门规章、业务规则 和公司章程等规定。本次任命未导致董事会中兼任高级管理人员的董事和由职工代表担 任的董事人数超过公司董事总数的二分之一；董事会中独立 ...

证券代码：839729 证券简称：永顺生物 公告编号：2025-089 广东永顺生物制药股份有限公司（以下简称"公司"）于2025年9月12日召 开第五届董事会第十二次会议，审议通过《关于调整公司第五届董事会战略委员 会委员的议案》，现将有关情况公告如下： 一、基本情况 根据《中华人民共和国公司法》《上市公司独立董事管理办法》《北京证券 交易所股票上市规则》等相关法律、法规及规范性文件以及《公司章程》的有关 规定，公司于 2025 年 9 月 12 日召开 2025 年第一次临时股东会，审议通过了《关 于选举公司第五届董事会非独立董事的议案》《关于选举公司第五届董事会独立 董事的议案》，选举吴锋先生为公司第五届董事会董事，选举亓文宝先生为公司 第五届董事会独立董事。 为进一步完善公司治理结构，充分发挥战略委员会在公司治理中的作用，根 据相关法律、法规及《公司章程》等有关规定，公司董事会决定对第五届董事会 战略委员会成员进行调整，增加两名委员。本次调整后，战略委员会成员由 3 名增加至 5 名。 调整前第五届董事会战略委员会成员：谭德明（主任委员）、梅盈洁、欧敬。 调整后第五届董事会战略委员会成员：谭德明（主任 ...

证券代码：839729 证券简称：永顺生物 公告编号：2025-093 广东永顺生物制药股份有限公司 关于参加 2025 年广东辖区上市公司投资者集体 接待日活动暨半年度业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 为进一步加强与投资者的互动交流，广东永顺生物制药股份有限公司（以下 简称"公司"）将参加由中国证券监督管理委员会广东监管局、广东上市公司协 会与深圳市全景网络有限公司联合举办的广东辖区上市公司投资者集体接待日 暨辖区上市公司半年度业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：2025 年 9 月 19 日（周五）15:30-17:00。 （二）会议召开地点 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP，参 与本次互动交流。 三、 参加人员 公司董事、总经理：吴锋先生 公司副总经理、财务负责人：李秋红女士 公司副总经理、董事会 ...